neurotensin (Human) [5729]



neurotensin (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)O
InChIKey PCJGZPGTCUMMOT-ISULXFBGSA-N
Sequence XLYENKPRRPYIL
HELM PEPTIDE1{[Glp].L.Y.E.N.K.P.R.R.P.Y.I.L}$$$$

Chemical Properties

Hydrogen bond acceptors 21
Hydrogen bond donors 21
Rotatable bonds 50
Log P -3.809
Molecular weight (Da) 1671.9
Stereochemistry info partial


No bioactivity data available.

neurotensin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.